Insertional Achilles Tendinopathy
Investigational use for insertional Achilles tendinopathy; no clinical study of leech therapy for it was identified.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for insertional Achilles tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy for insertional Achilles tendinopathy, controlled or uncontrolled, was identified. Evidence-based care: heel lifts and supportive footwear, activity modification, eccentric calf strengthening modified for insertional disease (the strongest tendinopathy evidence), heavy slow-resistance training, NSAIDs for short-term symptoms, extracorporeal shock-wave therapy (modest RCT support), and (refractory) PRP, ultrasound-guided needling, or surgical debridement with Haglund deformity excision. Corticosteroid injection is generally avoided because of rupture risk.
- Main risks
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the posterior heel or distal Achilles for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- RISK if placed directly on the Achilles tendon - direct trauma may precipitate rupture
- Septic bursitis if a contaminated bite penetrates near the retrocalcaneal bursa
- Worsening tendon pain from local irritation
- Delay of evidence-based heavy slow-resistance training - the highest-evidence intervention
- Who should not consider this
- Patients with suspected partial or complete Achilles tendon rupture (surgical emergency)
- Patients on fluoroquinolone antibiotics (tendon rupture risk)
- Patients with diabetes, peripheral arterial disease, or impaired protective sensation
- Patients with recent corticosteroid injection at the site (within 4 weeks)
- Patients who have not completed at least 12 weeks of eccentric calf strengthening modified for insertional disease
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients with active dermatitis or broken skin over the posterior heel
- What to ask your clinician
- Have I had ultrasound or MRI to characterize the tendon and rule out partial or complete tear?
- Have we ruled out retrocalcaneal bursitis, Haglund deformity, or systemic enthesitis (spondyloarthropathy)?
- Have I completed a structured 12-week eccentric or heavy slow-resistance training program modified for insertional disease?
- Have I tried heel lifts, supportive footwear, and activity modification?
- Have I tried ESWT, and what is its evidence vs. this investigational option?
- Where exactly will leeches be placed - confirm placement is adjacent to (NOT directly on) the Achilles tendon?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Sudden pop, severe pain, and inability to plantarflex the foot (Achilles rupture - surgical emergency)
- Acute severe ankle swelling with warmth (possible septic bursitis)
- Calf swelling, redness, or warmth (possible DVT)
- Bleeding from a bite site lasting more than 24 hours
- Fever, chills, or spreading redness at the bite site
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for insertional Achilles tendinopathy.
- No controlled trials support efficacy specifically for insertional disease.
- It does not replace eccentric or heavy slow-resistance training, which has the strongest tendinopathy evidence.
- It does not address Achilles rupture, which is a surgical emergency.
- Direct trauma to the tendon may precipitate rupture - placement must be adjacent, not over the tendon.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M76.61, M76.62, M77.51
- Safety tier
- Low
Evidence Summary
Insertional Achilles tendinopathy (often coexisting with Haglund deformity and retrocalcaneal bursitis) responds less well than mid-substance disease to all conservative modalities. No clinical study of leech therapy for Achilles tendinopathy (controlled trial, case series or case report) was identified in PubMed, Europe PMC, trial registries or the Russian-language sources searched; use is investigational and mechanistic only, with a speculative local anti-inflammatory rationale on the enthesopathy. The nearest controlled evidence found is a randomized trial of leech therapy versus topical diclofenac in chronic lateral epicondylitis (Bäcker et al. 2011, 40 patients), which does not establish an effect at the Achilles. Eccentric loading with a reduced dorsiflexion arc and shockwave therapy remain first-line, and surgical debridement is considered after roughly six months of conservative failure.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Acute Achilles rupture (surgical)
- Recent local corticosteroid injection (<4 weeks)
- Active retrocalcaneal bursitis with infection
Related Conditions
Mid-Substance Achilles Tendinopathy
Investigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.
Plantar Fasciitis
Investigational use; no clinical study of leech therapy for plantar fasciitis was identified, and the rationale is mechanistic only.
Calcaneal Heel Spur (Symptomatic)
Investigational use for symptomatic plantar calcaneal spur; distinguished from plantar fasciitis by radiographic spur with localized pain.
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.